0.18Open0.05Pre Close50 Volume5.09K Open Interest5.00Strike Price900.00Turnover57.58%IV13.35%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.18Extrinsic Value100Contract SizeAmericanOptions Type0.3072Delta0.5118Gamma36.56Leverage Ratio-0.0050Theta0.0009Rho11.23Eff Leverage0.0042Vega
Allot Stock Discussion
📊⚡️📊
Positive
First non-GAAP operating profit ($1.1M) in three years
SECaaS revenues grew 69% YoY to $4.7M
Revenue increased 5% sequentially and 3% YoY to $23.2M
Non-GAAP gross margin improved to 71.7%
Generated positive operating cash flow of $1.9M
Net cash increased by $2.0M vs previous quarter
Negative
GAAP operating loss of $0.2M
GAAP net loss of $0.2M ($0.01 per share)
$Allot (ALLT.US)$ buy in 7.82 sell 12.25 after 8.23 the gaps are 9.76, 10.40, 11.34, 11.84 12.08.
$Synchronoss Technologies (SNCR.US)$ Buy in 1.59 sell 2.23.
$Puma Biotechnology (PBYI.US)$ buy in 2.72 sell 6.48.
$Avalo Therapeutics (AVTX.US)$ buy in .64. sell 1.76. Institutional investor has continued buying but the price may not have found bottom yet.
No comment yet